SAT0324 ARTICULAR MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

Volume: 78, Pages: 1240 - 1241
Published: Jun 1, 2019
Abstract
Background: null Vedolizumab (VDZ) is a humanized IgG1 monoclonal antibody anti-α4β7 integrin agent used in inflammatory bowel disease (IBD). It has been incriminated in occurrence of articular manifestations but, as it is given in most cases after anti-TNFα therapy, it is not known if these articular manifestations are linked to IBD-associated arthritis and unmasked by withdrawal of anti-TNFα or are more directly linked to VDZ. null Objectives:...
Paper Details
Title
SAT0324 ARTICULAR MANIFESTATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB
Published Date
Jun 1, 2019
Volume
78
Pages
1240 - 1241
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.